Zurich Insurance Group’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $11.1M | Sell |
123,181
-2,917
| -2% | -$244K | 0.08% | 194 |
|
|
2026
Q1 | $10.1M | Buy |
+126,098
| New | +$10.4M | 0.08% | 218 |
|
|
2025
Q3 | – | Sell |
-458,174
| Closed | -$35.8M | – | 294 |
|
|
2025
Q2 | $35.8M | Buy |
+458,174
| New | +$34.2M | 0.28% | 85 |
|
|
2022
Q4 | – | Sell |
-363,800
| Closed | -$30.1M | – | 230 |
|
|
2022
Q3 | $30.1M | Buy |
363,800
+30,171
| +9% | +$2.9M | 0.47% | 73 |
|
|
2022
Q2 | $31.7M | Sell |
333,629
-172,770
| -34% | -$17.9M | 0.47% | 77 |
|
|
2022
Q1 | $59.6M | Sell |
506,399
-148,337
| -23% | -$16.6M | 0.74% | 49 |
|
|
2021
Q4 | $84.8M | Buy |
654,736
+442,786
| +209% | +$51.6M | 0.96% | 37 |
|
|
2021
Q3 | $24M | Buy |
211,950
+4,689
| +2% | +$535K | 0.29% | 70 |
|
|
2021
Q2 | $21.5M | Buy |
+207,261
| New | +$19.5M | 0.27% | 68 |
|
|
2021
Q1 | – | Sell |
-1,213,369
| Closed | -$111M | – | 213 |
|
|
2020
Q4 | $111M | Buy |
1,213,369
+357,407
| +42% | +$29.6M | 1.63% | 26 |
|
|
2020
Q3 | $68.3M | Buy |
855,962
+380,455
| +80% | +$29.7M | 1.18% | 34 |
|
|
2020
Q2 | $32.9M | Buy |
475,507
+132,175
| +38% | +$9.39M | 0.56% | 46 |
|
|
2020
Q1 | $21.6M | Buy |
+343,332
| New | +$24.8M | 0.46% | 54 |
|
|
2019
Q4 | – | Sell |
-107,967
| Closed | -$7.91M | – | 318 |
|
|
2019
Q3 | $7.91M | Buy |
107,967
+3,573
| +3% | +$251K | 0.15% | 171 |
|
|
2019
Q2 | $6.43M | Buy |
104,394
+4,095
| +4% | +$248K | 0.13% | 207 |
|
|
2019
Q1 | $6.4M | Buy |
+100,299
| New | +$5.72M | 0.14% | 199 |
|
|
2018
Q3 | – | Sell |
-153,888
| Closed | -$7.47M | – | 475 |
|
|
2018
Q2 | $7.47M | Sell |
153,888
-1,167
| -0.8% | -$54.5K | 0.17% | 176 |
|
|
2018
Q1 | $7.21M | Buy |
155,055
+33,102
| +27% | +$1.44M | 0.17% | 171 |
|
|
2017
Q4 | $4.58M | Buy |
121,953
+76,677
| +169% | +$2.81M | 0.11% | 228 |
|
|
2017
Q3 | $1.65M | Sell |
45,276
-88,911
| -66% | -$3.39M | 0.05% | 424 |
|
|
2017
Q2 | $5.29M | Buy |
134,187
+28,683
| +27% | +$1.05M | 0.15% | 162 |
|
|
2017
Q1 | $3.31M | Sell |
105,504
-51,831
| -33% | -$1.62M | 0.1% | 255 |
|
|
2016
Q4 | $4.91M | Sell |
157,335
-15,216
| -9% | -$493K | 0.16% | 167 |
|
|
2016
Q3 | $6.93M | Buy |
172,551
+92,289
| +115% | +$3.48M | 0.23% | 114 |
|
|
2016
Q2 | $2.67M | Sell |
80,262
-84,246
| -51% | -$2.88M | 0.09% | 236 |
|
|
2016
Q1 | $4.84M | Sell |
164,508
-255,042
| -61% | -$7.04M | 0.17% | 161 |
|
|
2015
Q4 | $11M | Sell |
419,550
-49,110
| -10% | -$1.28M | 0.4% | 76 |
|
|
2015
Q3 | $11.1M | Buy |
+468,660
| New | +$11.3M | 0.41% | 90 |
|
Other funds holding EW
Zurich Insurance Group's EW Position: Q2 2026 in Review
Zurich Insurance Group reduced its Edwards Lifesciences (EW) stake by 2.3% in Q2 2026, selling an estimated $244K and leaving 123,181 shares worth $11.1M. The position accounts for 0.08% of the portfolio, ranked #194.
Zurich Insurance Group first reported a position in EW in Q3 2015 and has held it in 28 quarters since. The position peaked at $111M in Q4 2020. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Zurich Insurance Group held 123,181 shares of Edwards Lifesciences worth $11.1M as of Q2 2026.
- Zurich Insurance Group sold 2,917 Edwards Lifesciences shares in Q2 2026, an estimated $244K.
- Edwards Lifesciences made up 0.08% of Zurich Insurance Group's portfolio in Q2 2026, its #194 holding.
- Zurich Insurance Group first reported a position in Edwards Lifesciences in Q3 2015 and has held it in 28 quarters since.
- Zurich Insurance Group's Edwards Lifesciences position peaked at $111M in Q4 2020.
- 1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Zurich Insurance Group's 13F filing for Q2 2026, filed 14 Aug 2026.